Education
About Us
Working with TipRanks
Follow Us
Syra Health Corp. Class A (SYRA)
OTHER OTC:SYRA
SYRA Stock Chart & Stats
$0.09
-$0.12(-16.06%)
At close: 4:00 PM EST
$0.09
-$0.12(-16.06%)
Day’s Range― - ―
52-Week Range$0.03 - $0.46
Previous CloseN/A
Volume2.20M
Average Volume (3M)9.76K
Market Cap
$1.12M
Enterprise Value-$655.64K
Total Cash (Recent Filing)$1.98M
Total Debt (Recent Filing)$232.35K
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding11,339,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.04
Price to Sales (P/S)0.37
P/FCF Ratio-1.02
Enterprise Value/Market Cap-0.58
Enterprise Value/Revenue-0.09
Enterprise Value/Gross Profit-0.28
Enterprise Value/Ebitda0.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Leadership Upgrade — New CEOAppointment of a CEO with deep Medicare/Medicaid and population-health experience is a structural capability boost. Over months this should improve contract win rates, execution on government programs and strategic partnerships, aligning management skills with Syra’s target markets.
Improving Profitability TrendsMaterial margin expansion and a much smaller net loss margin reflect improving unit economics and tighter cost control. If sustained, higher gross margins enable operating leverage as revenue stabilizes, shortening the path to sustainable profitability and reinvestment capacity.
Manageable LeverageLow leverage reduces interest burden and financial distress risk, giving the company flexibility to invest in program delivery and sales to win government contracts. Improved capital structure versus 2022 (>1x) provides a more durable runway while cash flow recovery is pursued.
Bears Say
Ongoing UnprofitabilityPersistent negative operating profit and net losses weaken internal funding, can erode equity over time, and limit reinvestment. Until operating profitability is achieved, growth initiatives depend on external capital which constrains long-term strategic independence and scale.
Negative Cash GenerationOngoing negative operating and free cash flow means the business is not yet self-funding and remains reliant on financing or balance-sheet resources. This limits ability to invest in technology, staffing, or contract expansion and increases vulnerability to liquidity shocks.
Revenue ContractionA multi-period revenue decline undermines scale advantages and makes fixed-cost absorption harder, slowing margin recovery. For a services firm dependent on government contracts, shrinking revenue raises questions about contract retention and competitive positioning over the next several quarters.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.03 and its highest was $0.46 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $1.12M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is Mar 30, 2026 which is in 41 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on Nov 12, 2025. The company reported -$0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.019.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 11,339,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of -$0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―
Ownership Overview
Options Prices
Currently, No data available
---